Send to printer »

GEN News Highlights : Dec 5, 2006

Oxford Gene Technology Tapped to Provide Microarrays for HIV Vaccine Research

Oligonucleotide microarrays needed to study genes of interest involved in early cellular immune response.

Oxford Gene Technology (OGT) will design and fabricate microarrays for the Innate Discovery Team as part of the Centre for HIV-AIDS Vaccine Immunology (CHAVI) project.

OGT will design and develop an optimized oligonucleotide microarray to study genes of interest involved in the cellular immune response in early-stage HIV infected patients. The microarrays will be printed using the OGT ink jet in-situ synthesis platform. It will also investigate the use of its Multi Sample Array format enabling the parallel analysis of multiple samples. This will effectively reduce the cost per sample and speed up sample processing time.